These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9278616)

  • 21. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.
    Mwengee W; Butler T; Mgema S; Mhina G; Almasi Y; Bradley C; Formanik JB; Rochester CG
    Clin Infect Dis; 2006 Mar; 42(5):614-21. PubMed ID: 16447105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
    Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
    Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
    Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ultrastructural changes in liver of white mice, caused by isogenic F1+ and F1- strains of the plague pathogen, and correction of them with ceftriaxone].
    Bardakhch'ian EA; Ryzhko IV; Pasiukov VV; Samokhodkina ED
    Biull Eksp Biol Med; 1996 May; 121(5):589-93. PubMed ID: 8744147
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunohistochemical detection of Yersinia pestis in formalin-fixed, paraffin-embedded tissue.
    Guarner J; Shieh WJ; Greer PW; Gabastou JM; Chu M; Hayes E; Nolte KB; Zaki SR
    Am J Clin Pathol; 2002 Feb; 117(2):205-9. PubMed ID: 11863216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of ampicillin on the plague microbe (Y. pestis EV) according to electron microscopic data].
    Gorbaseva TI; Makarovskaia LN; Miliutin VN; Kirdeev VK
    Antibiotiki; 1980 Jul; 25(7):503-7. PubMed ID: 7406460
    [No Abstract]   [Full Text] [Related]  

  • 30.
    Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating time postinoculation into a dose-response model of Yersinia pestis in mice.
    Huang Y; Bartrand TA; Haas CN; Weir MH
    J Appl Microbiol; 2009 Sep; 107(3):727-35. PubMed ID: 19302316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
    Powell BS; Andrews GP; Enama JT; Jendrek S; Bolt C; Worsham P; Pullen JK; Ribot W; Hines H; Smith L; Heath DG; Adamovicz JJ
    Biotechnol Prog; 2005; 21(5):1490-510. PubMed ID: 16209555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A rapid diagnostic test for plague detects Yersinia pestis F1 antigen in ancient human remains].
    Bianucci R; Rahalison L; Ferroglio E; Massa ER; Signoli M
    C R Biol; 2007 Oct; 330(10):747-54. PubMed ID: 17905394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Yersinia pestis as a dangerous biological weapon].
    Grygorczuk S; Hermanowska-Szpakowicz T
    Med Pr; 2002; 53(4):343-8. PubMed ID: 12474416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV
    Antibiot Khimioter; 2001; 46(4):16-8. PubMed ID: 11550501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel mechanism of streptomycin resistance in Yersinia pestis: Mutation in the rpsL gene.
    Dai R; He J; Zha X; Wang Y; Zhang X; Gao H; Yang X; Li J; Xin Y; Wang Y; Li S; Jin J; Zhang Q; Bai J; Peng Y; Wu H; Zhang Q; Wei B; Xu J; Li W
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009324. PubMed ID: 33886558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents.
    Frean J; Klugman KP; Arntzen L; Bukofzer S
    J Antimicrob Chemother; 2003 Aug; 52(2):294-6. PubMed ID: 12865386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of several antibiotics and their combination with prodigiozan on Y. pestis EV, engulfed by macrophages].
    Popova GO; Vinidchenko NN; Mikhalevich RV; Sokolova MT; Makarovskaia LN
    Antibiotiki; 1977 Apr; 22(4):348-53. PubMed ID: 883789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A horizontally acquired filamentous phage contributes to the pathogenicity of the plague bacillus.
    Derbise A; Chenal-Francisque V; Pouillot F; Fayolle C; Prévost MC; Médigue C; Hinnebusch BJ; Carniel E
    Mol Microbiol; 2007 Feb; 63(4):1145-57. PubMed ID: 17238929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
    Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.